Bavarian Nordic delivers smallpox vaccine to US under $549m contract
This article was originally published in Scrip
Executive Summary
Bavarian Nordic has delivered 20 million doses of its smallpox vaccine Imvamune to the US government for its Strategic National Stockpile (SNS) – a cache of medical products and other supplies intended for use to address large-scale emergencies – completing a decade-long research and development partnership valued at $549m.